Analyst Consensus ?
ConsensusHold44 ratings
Bullish2147.7%
Neutral2250.0%
Bearish12.3%
FN2 Earnings Intelligence
Humana Inc. analyst ratings
Humana Inc. (HUM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$414.85Previous close
$180Low
$425.94Average
$652High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Oct 13, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 12, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | Oct 12, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 9, 2026 |
| Baird | Outperform | Neutral | Upgrade | Oct 9, 2026 |
| Cantor Fitzgerald | Overweight | Neutral | Upgrade | Oct 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 10, 2026 |
| Morgan Stanley | Equal Weight | Underweight | Upgrade | Aug 5, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 31, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 30, 2026 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jul 30, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Jul 13, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 24, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | May 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | May 13, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Feb 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 12, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Argus Research | Hold | Hold | Maintain | Aug 14, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 9, 2024 |
| Leerink Partners | Market Perform | Outperform | Downgrade | Oct 2, 2024 |
| SVB Securities | Outperform | Outperform | Maintain | Apr 27, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 6, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 6, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Nov 3, 2022 |
| Citigroup | Buy | Buy | Maintain | Apr 29, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Sep 30, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Aug 1, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 2, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jan 24, 2017 |
| Stifel | Hold | Buy | Downgrade | Jan 24, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 9, 2015 |
| Wedbush | Neutral | Outperform | Downgrade | Jul 6, 2015 |
| Sterne Agee CRT | Neutral | Underperform | Upgrade | Jun 3, 2015 |
| Sterne Agee | Neutral | Underperform | Upgrade | Jun 3, 2015 |
| Leerink Swann | Outperform | Outperform | Maintain | Jun 1, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Nov 10, 2014 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $414.85. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $495 | $433.5 | +19.3% | Oct 13, 2026 |
| Oppenheimer | Analyst unavailable | $525 | $430.16 | +26.6% | Oct 12, 2026 |
| UBS | Analyst unavailable | $495 | $431.5 | +19.3% | Oct 12, 2026 |
| Truist Financial | David MacDonald | $475 | $431.03 | +14.5% | Oct 12, 2026 |
| Raymond James | Analyst unavailable | $520 | $431.03 | +25.3% | Oct 12, 2026 |
| Oppenheimer | Analyst unavailable | $475 | $387.12 | +14.5% | Oct 9, 2026 |
| Barclays | Analyst unavailable | $582 | $387.12 | +40.3% | Oct 9, 2026 |
| UBS | Analyst unavailable | $596 | $387.12 | +43.7% | Oct 9, 2026 |
| Robert W. Baird | Michael Ha | $596 | $387.12 | +43.7% | Oct 9, 2026 |
| Raymond James | Sarah James | $460 | $404.28 | +10.9% | Oct 7, 2026 |
| Barclays | Analyst unavailable | $515 | $379.96 | +24.1% | Sep 25, 2026 |
| Wolfe Research | Justin Lake | $450 | $378.87 | +8.5% | Aug 24, 2026 |
| Morgan Stanley | Analyst unavailable | $370 | $362.16 | -10.8% | Aug 4, 2026 |
| Barclays | Analyst unavailable | $407 | $366.61 | -1.9% | Jul 31, 2026 |
| Piper Sandler | Analyst unavailable | $463 | $369.62 | +11.6% | Jul 30, 2026 |
| UBS | Analyst unavailable | $405 | $367.84 | -2.4% | Jul 30, 2026 |
| Oppenheimer | Michael Wiederhorn | $405 | $367.16 | -2.4% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $390 | $365.89 | -6.0% | Jul 30, 2026 |
| Guggenheim | Analyst unavailable | $471 | $365.89 | +13.5% | Jul 30, 2026 |
| Leerink Partners | Analyst unavailable | $513 | $365.89 | +23.7% | Jul 30, 2026 |
| Evercore ISI | Analyst unavailable | $480 | $365.45 | +15.7% | Jul 29, 2026 |
| Jefferies | Analyst unavailable | $410 | $398.25 | -1.2% | Jul 20, 2026 |
| Truist Financial | David MacDonald | $415 | $406 | +0.0% | Jul 14, 2026 |
| Wells Fargo | Stephen Baxter | $502 | $392.22 | +21.0% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $415 | $401.34 | +0.0% | Jul 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $392.86 | -27.7% | Jul 7, 2026 |
| Raymond James | Sarah James | $300 | $392.86 | -27.7% | Jul 7, 2026 |
| Mizuho Securities | Analyst unavailable | $390 | $350.08 | -6.0% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $249 | $327.54 | -40.0% | Jun 4, 2026 |
| Bernstein | Analyst unavailable | $425 | $320.88 | +2.4% | Jun 3, 2026 |
| Truist Financial | David MacDonald | $320 | $305.42 | -22.9% | Jun 1, 2026 |
| Barclays | Analyst unavailable | $344 | $300.86 | -17.1% | May 26, 2026 |
| UBS | Analyst unavailable | $320 | $303.68 | -22.9% | May 22, 2026 |
| Mizuho Securities | Analyst unavailable | $335 | $310.55 | -19.2% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $441 | $310.55 | +6.3% | May 20, 2026 |
| Morgan Stanley | Erin Wright | $217 | $301.35 | -47.7% | May 15, 2026 |
| Piper Sandler | Analyst unavailable | $254 | $295.35 | -38.8% | May 13, 2026 |
| Raymond James | Analyst unavailable | $260 | $236.44 | -37.3% | May 1, 2026 |
| RBC Capital | Ben Hendrix | $246 | $240.92 | -40.7% | Apr 30, 2026 |
| Deutsche Bank | Analyst unavailable | $235 | $241.1 | -43.4% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $260 | $242.68 | -37.3% | Apr 30, 2026 |
| Truist Financial | David MacDonald | $270 | $243.12 | -34.9% | Apr 30, 2026 |
| Guggenheim | Analyst unavailable | $269 | $243.12 | -35.2% | Apr 30, 2026 |
| UBS | Analyst unavailable | $262 | $243.12 | -36.8% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $180 | $243.12 | -56.6% | Apr 30, 2026 |
| Evercore ISI | Analyst unavailable | $195 | $198.39 | -53.0% | Apr 8, 2026 |
| Mizuho Securities | Analyst unavailable | $258 | $198.39 | -37.8% | Apr 8, 2026 |
| Wells Fargo | Analyst unavailable | $206 | $184.99 | -50.3% | Feb 18, 2026 |
| Truist Financial | Analyst unavailable | $200 | $185.36 | -51.8% | Feb 17, 2026 |
| Deutsche Bank | George Hill | $180 | $182.87 | -56.6% | Feb 13, 2026 |
| UBS | Analyst unavailable | $195 | $176.24 | -53.0% | Feb 12, 2026 |
| Raymond James | Sarah James | $201 | $177.74 | -51.5% | Feb 12, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $173.81 | -39.7% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $146 | $175.4 | -64.8% | Feb 12, 2026 |
| Guggenheim | Analyst unavailable | $252 | $175.4 | -39.3% | Feb 12, 2026 |
| RBC Capital | Ben Hendrix | $189 | $175.4 | -54.4% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $174 | $195.2 | -58.1% | Feb 2, 2026 |
| Wells Fargo | Analyst unavailable | $290 | $279.84 | -30.1% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $344 | $281.03 | -17.1% | Jan 6, 2026 |
| Morgan Stanley | Erin Wright | $262 | $260.28 | -36.8% | Dec 18, 2025 |
| Jefferies | David Windley | $313 | $253.02 | -24.6% | Dec 5, 2025 |
| Barclays | Andrew Mok | $234 | $229.2 | -43.6% | Nov 25, 2025 |
| Truist Financial | Analyst unavailable | $285 | $242.75 | -31.3% | Nov 10, 2025 |
| Truist Financial | Analyst unavailable | $300 | $266.92 | -27.7% | Oct 14, 2025 |
| Goldman Sachs | Scott Fidel | $235 | $271 | -43.4% | Oct 14, 2025 |
| Mizuho Securities | Ann Hynes | $345 | $298.04 | -16.8% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $347 | $295.2 | -16.4% | Oct 7, 2025 |
| Mizuho Securities | Analyst unavailable | $300 | $256.62 | -27.7% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $245 | $256.62 | -40.9% | Oct 3, 2025 |
| Barclays | Andrew Mok | $315 | $312 | -24.1% | Sep 4, 2025 |
| Barclays | Andrew Mok | $325 | $311.98 | -21.7% | Sep 4, 2025 |
| Barclays | Andrew Mok | $275 | $261.47 | -33.7% | Jul 31, 2025 |
| Wells Fargo | Stephen Baxter | $348 | $217.14 | -16.1% | Jul 18, 2025 |
| Truist Financial | David MacDonald | $280 | $241.45 | -32.5% | Jun 17, 2025 |
| Barclays | Andrew Mok | $268 | $234.96 | -35.4% | Jun 12, 2025 |
| Deutsche Bank | George Hill | $248 | $287.64 | -40.2% | Dec 4, 2024 |
| Deutsche Bank | George Hill | $250 | $260.57 | -39.7% | Oct 22, 2024 |
| Barclays | Andrew Mok | $250 | $245.45 | -39.7% | Oct 10, 2024 |
| RBC Capital | Ben Hendrix | $265 | $236.29 | -36.1% | Oct 8, 2024 |
| Jefferies | David Windley | $253 | $240.03 | -39.0% | Oct 7, 2024 |
| Piper Sandler | Jessica Tassan | $274 | $239.32 | -34.0% | Oct 3, 2024 |
| Bank of America Securities | Kevin Fischbeck | $247 | $246.49 | -40.5% | Oct 2, 2024 |
| Jefferies | David Windley | $419 | $319.57 | +1.0% | Sep 27, 2024 |
| RBC Capital | Frank Morgan | $400 | $364.06 | -3.6% | Sep 5, 2024 |
| Oppenheimer | Michael Wiederhorn | $400 | $361.61 | -3.6% | Aug 1, 2024 |
| Truist Financial | David MacDonald | $400 | $382.22 | -3.6% | Jul 15, 2024 |
| Piper Sandler | Jessica Tassan | $392 | $355.8 | -5.5% | Jun 25, 2024 |
| Barclays | Andrew Mok | $370 | $349.55 | -10.8% | Jun 20, 2024 |
| Oppenheimer | Michael Wiederhorn | $370 | $315.98 | -10.8% | Apr 25, 2024 |
| RBC Capital | Frank Morgan | $353 | $315.98 | -14.9% | Apr 25, 2024 |
| Cantor Fitzgerald | Sarah James | $360 | $315.98 | -13.2% | Apr 25, 2024 |
| Barclays | Andrew Mok | $310 | $351.45 | -25.3% | Apr 2, 2024 |
| Truist Financial | Analyst unavailable | $560 | $474.1 | +35.0% | Feb 7, 2023 |
| Cowen & Co. | Analyst unavailable | $581 | $484.71 | +40.1% | Feb 6, 2023 |
| Credit Suisse | Analyst unavailable | $575 | $476.57 | +38.6% | Feb 6, 2023 |
| UBS | Analyst unavailable | $620 | $486.02 | +49.5% | Feb 2, 2023 |
| J.P. Morgan | Analyst unavailable | $625 | $492.54 | +50.7% | Jan 6, 2023 |
| Goldman Sachs | Nathan Rich | $652 | $528.9 | +57.2% | Dec 13, 2022 |
| Mizuho Securities | Analyst unavailable | $615 | $558.3 | +48.2% | Nov 10, 2022 |
| RBC Capital | Analyst unavailable | $544 | $505.88 | +31.1% | Sep 20, 2022 |
| Truist Financial | Analyst unavailable | $570 | $493.38 | +37.4% | Sep 16, 2022 |
| Oppenheimer | Analyst unavailable | $550 | $491.49 | +32.6% | Sep 16, 2022 |
| Morgan Stanley | Analyst unavailable | $494 | $474.44 | +19.1% | Aug 2, 2022 |
| Barclays | Analyst unavailable | $570 | $478.35 | +37.4% | Jul 28, 2022 |
| Mizuho Securities | Analyst unavailable | $529 | $478.35 | +27.5% | Jul 28, 2022 |
| Oppenheimer | Analyst unavailable | $520 | $478.35 | +25.3% | Jul 28, 2022 |
| Leerink Partners | Analyst unavailable | $540 | $478.35 | +30.2% | Jul 28, 2022 |
| Truist Financial | David MacDonald | $550 | $491.79 | +32.6% | Jul 26, 2022 |
| Wells Fargo | Analyst unavailable | $514 | $443 | +23.9% | May 25, 2022 |
| Wells Fargo | Analyst unavailable | $512 | $457.31 | +23.4% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $541 | $442.3 | +30.4% | Apr 28, 2022 |
| Leerink Partners | Analyst unavailable | $535 | $443.37 | +29.0% | Apr 28, 2022 |
| UBS | Kevin Caliendo | $520 | $453.97 | +25.3% | Apr 19, 2022 |
| Truist Financial | David MacDonald | $490 | $451.33 | +18.1% | Apr 11, 2022 |
| UBS | Kevin Caliendo | $486 | $362.52 | +17.2% | Jan 7, 2022 |
| Barclays | Steven Valiquette | $490 | $362.52 | +18.1% | Jan 7, 2022 |
| Goldman Sachs | Nathan Rich | $472 | $460.34 | +13.8% | Dec 14, 2021 |
| Oppenheimer | Michael Wiederhorn | $510 | $452.06 | +22.9% | Nov 4, 2021 |
| Credit Suisse | A.J. Rice | $513 | $452.06 | +23.7% | Nov 4, 2021 |
| Bank of America Securities | Kevin Fischbeck | $530 | $452.06 | +27.8% | Nov 4, 2021 |
| Cantor Fitzgerald | Steven Halper | $480 | $457.94 | +15.7% | Nov 3, 2021 |
| Cowen & Co. | Gary Taylor | $479 | $415.01 | +15.5% | Sep 9, 2021 |
| Evercore ISI | Michael Newshel | $450 | $424.06 | +8.5% | Aug 4, 2021 |
| Stephens | Scott Fidel | $500 | $423.34 | +20.5% | Aug 3, 2021 |
| J.P. Morgan | Lisa Gill | $514 | $453.35 | +23.9% | Jul 9, 2021 |
| Wolfe Research | Justin Lake | $498 | $443.19 | +20.0% | Apr 26, 2021 |
Track every rating change on HUM the moment it posts. Free to start.
Start freeGet the HUM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.